demonstrated that the tumor suppressor MAGI2−AS3 may regulate the expression of MAGI2 through a cis-acting mechanism, and overexpression of MAGI2‐AS3 leads to a reduction in the number of MAGI2 methylated CpG sites, leading to the up-regulation of MAGI2. The gene discussed is PDS5B; the disease is neoplasm.